Schonfeld Strategic Advisors LLC - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 75 filers reported holding UNITY BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 5.59 and the average weighting 0.0%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q1 2022$43,0000.0%38,700
+172.5%
0.00%
Q3 2021$43,000
-48.2%
14,200
-20.7%
0.00%
-100.0%
Q2 2021$83,000
-28.4%
17,900
-46.7%
0.00%
-50.0%
Q3 2020$116,00033,6000.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
Mayo Clinic 1,571,981$9,117,00023.05%
Invus Financial Advisors, LLC 2,189,998$12,702,0006.24%
Leap Investments LP 13,400$78,0000.11%
Moloney Securities Asset Management, LLC 51,950$301,0000.11%
Verity Asset Management, Inc. 14,748$86,0000.11%
Virtus ETF Advisers LLC 43,010$249,0000.10%
Investors Financial Group, LLC 15,850$92,0000.09%
SUNFLOWER BANK, NA WEALTH MANAGEMENT 20,000$116,0000.04%
Baillie Gifford 3,803,014$22,057,0000.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 315,047$1,827,0000.02%
View complete list of UNITY BIOTECHNOLOGY INC shareholders